Bioceres Crop Solutions (BIOX) Stock Price, News & Analysis

Company Overview

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Bolivia, Brazil, Colombia, Estonia, the United States, Paraguay, Russia, South Africa, France, Uruguay, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Key Stats

• Today's Range: $6.15 to $6.62
• 50-Day Range: $6.17 to $9.99
• 52-Week Range: $5.71 to $14.05
• Volume: 232,760 shs
• Average Volume: 202,429 shs
• Market Capitalization: $387.78 million
• P/E Ratio: 308.65
• Dividend Yield: N/A
• Price Target: $12.13
• Consensus Rating: Buy

Bioceres Crop Solutions Stock Analysis - MarketRank™

Bioceres Crop Solutions scored higher than 57% of companies evaluated by MarketBeat, and ranked 87th out of 143 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Buy

Consensus Rating

Bioceres Crop Solutions has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 4 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Bioceres Crop Solutions has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 416.67%

Earnings Growth

Earnings for Bioceres Crop Solutions are expected to grow by 416.67% in the coming year, from $0.12 to $0.62 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Bioceres Crop Solutions is 308.65, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 113.06.

Price to Earnings Ratio vs. Sector

The P/E ratio of Bioceres Crop Solutions is 308.65, which means that it is trading at a more expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 20.00.

Price to Book Value per Share Ratio

Bioceres Crop Solutions has a P/B Ratio of 1.12. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

2.32% of the float of Bioceres Crop Solutions has been sold short.

Short Interest Ratio / Days to Cover

Bioceres Crop Solutions has a short interest ratio ("days to cover") of 5.2.

Change versus previous month

Short interest in Bioceres Crop Solutions has recently increased by 20.69%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Bioceres Crop Solutions does not currently pay a dividend.

Dividend Growth

Bioceres Crop Solutions does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

2.32% of the float of Bioceres Crop Solutions has been sold short.

Short Interest Ratio / Days to Cover

Bioceres Crop Solutions has a short interest ratio ("days to cover") of 5.2.

Change versus previous month

Short interest in Bioceres Crop Solutions has recently increased by 20.69%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.07

News Sentiment

Bioceres Crop Solutions has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Consumer Staples companies.

News Coverage This Week

MarketBeat has tracked 25 news articles for Bioceres Crop Solutions this week, compared to 2 articles on an average week.

Search Interest

1 people have searched for BIOX on MarketBeat in the last 30 days.

MarketBeat Follows

Only 2 people have added Bioceres Crop Solutions to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Bioceres Crop Solutions insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 2.31% of the stock of Bioceres Crop Solutions is held by insiders.

Percentage Held by Institutions

Only 17.68% of the stock of Bioceres Crop Solutions is held by institutions.

BIOX Stock Analysis - Frequently Asked Questions

How have BIOX shares performed this year?

Bioceres Crop Solutions' stock was trading at $13.73 at the beginning of 2024. Since then, BIOX stock has decreased by 55.1% and is now trading at $6.17.
View the best growth stocks for 2024 here.

How were Bioceres Crop Solutions' earnings last quarter?

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) released its quarterly earnings data on Monday, November, 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by $0.11. The company had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a trailing twelve-month return on equity of 0.68%.

When did Bioceres Crop Solutions IPO?

Bioceres Crop Solutions (BIOX) raised $130 million in an initial public offering (IPO) on Wednesday, February 7th 2018. The company issued 11,800,000 shares at $10.00-$12.00 per share. Jefferies, Piper Jaffray, Santander and SunTrust Robinson Humphrey acted as the underwriters for the IPO and Mirabaud Securities was co-manager.

Who are Bioceres Crop Solutions' major shareholders?

Top institutional shareholders of Bioceres Crop Solutions include Fourth Sail Capital LP (5.05%), Royce & Associates LP (0.36%), Wellington Management Group LLP (0.34%) and Stifel Financial Corp (0.06%).

How do I buy shares of Bioceres Crop Solutions?

Shares of BIOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Bioceres Crop Solutions own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioceres Crop Solutions investors own include NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), Meta Platforms (META), Advanced Micro Devices (AMD), Builders FirstSource (BLDR) and CrowdStrike (CRWD).

Company Calendar

• Last Earnings: 11/11/2024
• Today: 11/17/2024
• Next Earnings (Estimated): 2/13/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Consumer Staples
• Industry: Agricultural chemicals
• Sub-Industry: Trading
• Current Symbol: NASDAQ:BIOX
• CUSIP: N/A
• CIK: 1769484
• Web: biocerescrops.com
• Phone: 543414861100
• Fax: N/A
• Employees: 500
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $12.13
• High Stock Price Target: $13.00
• Low Stock Price Target: $9.50
• Potential Upside/Downside: +96.5%
• Consensus Rating: Buy
• Rating Score (0-4): 3.33
• Research Coverage: 6 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $0.02
• Trailing P/E Ratio: 308.65
• Forward P/E Ratio: 18.70
• P/E Growth: N/A
• Net Income: $3.24 million
• Net Margins: 0.53%
• Pretax Margin: 1.33%
• Return on Equity: 0.68%
• Return on Assets: 0.28%

Debt

• Debt-to-Equity Ratio: 0.37
• Current Ratio: 1.27
• Quick Ratio: 0.86

Sales & Book Value

• Annual Sales: $464.80 million
• Price / Sales: 0.83
• Cash Flow: $0.35 per share
• Price / Cash Flow: 17.55
• Book Value: $5.50 per share
• Price / Book: 1.12

Miscellaneous

• Outstanding Shares: 62,850,000
• Free Float: 61,396,000
• Market Cap: $387.78 million
• Optionable: Optionable
• Beta: 0.49